J&J Pushes Back Launch Of Ottava Robotic Platform By Two Years
Executive Summary
The company originally expected the first-in-human trial of the soft-tissue robotic surgery system to begin in late 2022 and reach the market by 2023, but the company now expects those trials to begin in 2024.
You may also be interested in...
Minute Insight: Medtronic Brings Hugo RAS To Canada
Health Canada has licensed Hugo for urologic and gynecologic laparoscopic surgical procedures.
Medtronic’s Hugo Surgery Robot Enters European Market
Medtronic’s robotic-assisted surgery system earned a CE mark approval for urologic and gynecologic procedures, which make up about half of all robotic procedures.
AAOS 2021: Digital Tools In Surgical Ecosystem, Software-Enabled Tech, Robots, Wearables, Sensors
At the live AAOS conference, exhibitors, including major orthopedics players, demoed digital innovations, software-enabled technologies, robotics and smart implants that are expected to create efficiencies in the surgical continuum and provide data to improve outcomes.